Skip to main content
Top
Published in: Infection 6/2011

01-12-2011 | Correspondence

First case of gastrointestinal mucormycosis in an immunocompromised patient with gallbladder and duodenum involvement

Authors: E. Lacarrière, L. Lacaze, L. Schwarz, E. Huet, F. Lemoine, M. Scotté

Published in: Infection | Issue 6/2011

Login to get access

Excerpt

Mucormycosis is an infection caused by fungi from the Mucorales group. The first case of mucormycosis was described by Paltauf in 1885. It occurs mostly, but not exclusively, in immunodeficient patients. The most frequent predisposing affections are: hematological or solid malignancies, neutropenia, use of corticosteroids, solid organ or stem cell transplant, diabetic or metabolic acidosis, iron overload or deferoxamine use, and malnourishment [1]. The most commonly affected organs include, from the most to less frequent: brain and sinuses, lungs, skin, gastrointestinal (GI) tract, and miscellaneous [2]. Due to the lack of specific clinical symptoms and often altered states, early diagnosis is rarely obtained, leading to a high mortality rate. GI mucormycosis is a rare disease, often diagnosed post-mortem, usually associated with such symptoms as GI bleeding, abdominal pain and distension, and nausea and vomiting. We report the case of a patient with acute leukemia, who developed GI mucormycosis with gallbladder and suspected duodenal involvement. Extensive research was performed in the PubMed, Embase, and Ovid libraries, using the keywords mucormycosis, zygomycosis, gastrointestinal mucormycosis, necrotizing cholecystitis, peritonitis. No occurrence of mucormycosis with gallbladder or duodenal involvement was found. …
Literature
1.
go back to reference Mantadakis E, Samonis G. Clinical presentation of zygomycosis. Clin Microbiol Infect. 2009;15:15–20.PubMedCrossRef Mantadakis E, Samonis G. Clinical presentation of zygomycosis. Clin Microbiol Infect. 2009;15:15–20.PubMedCrossRef
2.
go back to reference Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556–69.PubMedCrossRef Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556–69.PubMedCrossRef
3.
go back to reference Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.PubMedCrossRef Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.PubMedCrossRef
4.
go back to reference Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10:31–47.PubMedCrossRef Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10:31–47.PubMedCrossRef
5.
go back to reference Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M, et al. Mucormycosis in hematologic patients. Haematologica. 2004;89:207–14.PubMed Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M, et al. Mucormycosis in hematologic patients. Haematologica. 2004;89:207–14.PubMed
6.
go back to reference Nosari A, Oreste P, Montillo M, Carrafiello G, Draisci M, Muti G, et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica. 2000;85:1068–71.PubMed Nosari A, Oreste P, Montillo M, Carrafiello G, Draisci M, Muti G, et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica. 2000;85:1068–71.PubMed
7.
8.
go back to reference Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99:331–6.PubMedCrossRef Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99:331–6.PubMedCrossRef
9.
go back to reference Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.PubMedCrossRef Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.PubMedCrossRef
10.
go back to reference Thomson SR, Bade PG, Taams M, Chrystal V. Gastrointestinal mucormycosis. Br J Surg. 1991;78:952–4.PubMedCrossRef Thomson SR, Bade PG, Taams M, Chrystal V. Gastrointestinal mucormycosis. Br J Surg. 1991;78:952–4.PubMedCrossRef
11.
go back to reference Karanth M, Taniere P, Barraclough J, Murray JA. A rare presentation of zygomycosis (mucormycosis) and review of the literature. J Clin Pathol. 2005;58:879–81.PubMedCrossRef Karanth M, Taniere P, Barraclough J, Murray JA. A rare presentation of zygomycosis (mucormycosis) and review of the literature. J Clin Pathol. 2005;58:879–81.PubMedCrossRef
12.
go back to reference Madrigal B, Arenal JJ, Torres A, Peñarrubia MJ, Vara A, Ruiz M, et al. Jejunal mucormycosis in a patient with Hodgkin’s lymphoma. Rev Esp Enferm Dig. 2008;100:507–10.PubMedCrossRef Madrigal B, Arenal JJ, Torres A, Peñarrubia MJ, Vara A, Ruiz M, et al. Jejunal mucormycosis in a patient with Hodgkin’s lymphoma. Rev Esp Enferm Dig. 2008;100:507–10.PubMedCrossRef
13.
go back to reference Oliver MR, Van Voorhis WC, Boeckh M, Mattson D, Bowden RA. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin Infect Dis. 1996;22:521–4.PubMedCrossRef Oliver MR, Van Voorhis WC, Boeckh M, Mattson D, Bowden RA. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin Infect Dis. 1996;22:521–4.PubMedCrossRef
14.
go back to reference Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N. Zygomycosis in solid organ transplant recipients: a prospective, matched case–control study to assess risks for disease and outcome. J Infect Dis. 2009;200:1002–11.PubMedCrossRef Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N. Zygomycosis in solid organ transplant recipients: a prospective, matched case–control study to assess risks for disease and outcome. J Infect Dis. 2009;200:1002–11.PubMedCrossRef
15.
go back to reference Scott-Conner CE, Fabrega AJ. Gastrointestinal problems in the immunocompromised host. A review for surgeons. Surg Endosc. 1996;10:959–64.PubMedCrossRef Scott-Conner CE, Fabrega AJ. Gastrointestinal problems in the immunocompromised host. A review for surgeons. Surg Endosc. 1996;10:959–64.PubMedCrossRef
16.
go back to reference Lo OS, Law WL. Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon’s perspective. World J Gastroenterol. 2010;16:1165–70.PubMedCrossRef Lo OS, Law WL. Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon’s perspective. World J Gastroenterol. 2010;16:1165–70.PubMedCrossRef
17.
go back to reference Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother. 2008;61:i35–40.PubMedCrossRef Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother. 2008;61:i35–40.PubMedCrossRef
18.
go back to reference Sakorafas GH, Tsolakides G, Grigoriades K, Bakoyiannis CN, Peros G. Colonic mucormycosis: an exceptionally rare cause of massive lower gastrointestinal bleeding. Dig Liver Dis. 2006;38:616–7.PubMedCrossRef Sakorafas GH, Tsolakides G, Grigoriades K, Bakoyiannis CN, Peros G. Colonic mucormycosis: an exceptionally rare cause of massive lower gastrointestinal bleeding. Dig Liver Dis. 2006;38:616–7.PubMedCrossRef
Metadata
Title
First case of gastrointestinal mucormycosis in an immunocompromised patient with gallbladder and duodenum involvement
Authors
E. Lacarrière
L. Lacaze
L. Schwarz
E. Huet
F. Lemoine
M. Scotté
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 6/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0165-x

Other articles of this Issue 6/2011

Infection 6/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.